Issue Date: January 30, 2017 | Web Date: January 26, 2017
Fighting buildup of tau protein in Alzheimer’s by targeting RNA
Efforts to treat Alzheimer’s disease by targeting the peptide amyloid-β have largely failed so far, but researchers are also pursuing another target: tau protein. Like amyloid-β, tau aggregates in the brains of Alzheimer’s patients.
Until now, strategies against tau have mainly involved the use of antibodies and small-molecule drugs. But Timothy M. Miller and colleagues at Washington University in St. Louis are taking a different approach. “We are turning down the production of the tau . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society